Search Within

Vanessa A Fabrizio

  1. "Pediatrics, Department of"
Formats
  1. Meeting Abstract (9)
  2. Journal Article (6)
  3. Research Letter (1)
Groups
  1. Pediatrics, Department of (16)
  2. Stem Cell Transplantation and Cellular Therapy Service (15)
  3. Biostatistics Service (7)
  4. Epidemiology and Biostatistics (7)
  5. Sloan Kettering Institute Postdocs (7)
  6. Tow Center for Developmental Oncology (TCDO) (7)

More Groups

People
  1. Kevin Curran (12)
  2. Audrey Mauguen (7)
  3. Richard O'Reilly (6)
  4. Susan Prockop (6)
  5. Jaap Jan Boelens (4)
  6. Andromachi Scaradavou (3)

More People

Years
  1. 2023 (2)
  2. 2022 (1)
  3. 2021 (6)
  4. 2020 (5)
  5. 2019 (2)
Publications
  1. Blood (4)
  2. Journal of Clinical Oncology (3)
  3. Pediatric Blood and Cancer (3)
  4. Blood Advances (2)
  5. Bone Marrow Transplantation (2)
  6. Biology of Blood and Marrow Transplantation (1)

More Publications

Publishers
  1. American Society of Hematology (6)
  2. American Society of Clinical Oncology (3)
  3. Wiley Periodicals, Inc (3)
  4. Nature Publishing Group (2)
  5. Elsevier Inc. (1)
  6. Elsevier Science Ltd. (1)

Results (16)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Real-world treatment of pediatric patients with relapsed/refractory B-cell acute lymphoblastic leukemia using tisagenlecleucel that is out of specification for commercial release
    Meeting Abstract

    Rossoff, J.; Baggott, C.; Prabhu, S.; Pacenta, H.; Phillips, C. L.; Stefanski, H.; Talano, J. A.; Moskop, A.; Margossian, S. P.; Verneris, M. R.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Baseline immune status predicts response to adoptive therapy with CMV CTLS for refractory CMV
    Meeting Abstract

    Fabrizio, V.; Rodriguez-Sanchez, I.; Mauguen, A.; Dahi, P.; Doubrovina, E.; O'Reilly, R. J.; Prockop, S.
    Bone Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Low toxicity and favorable overall survival in relapsed/refractory B-ALL following CAR T cells and CD34-selected T-cell depleted allogeneic hematopoietic cell transplant
    Journal Article

    Fabrizio, V. A.; Kernan, N. A.; Boulad, F.; Cancio, M.; Allen, J.; Higman, M.; Margossian, S. P.; Mauguen, A.; Prockop, S.; Scaradavou, A.; more...
    Bone Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Baseline immune status predicts response to adoptive therapy with CMV cytotoxic T-Cells for refractory CMV
    Meeting Abstract

    Fabrizio, V.; Rodriguez-Sanchez, I.; Mauguen, A.; Dahi, P. B.; O'Reilly, R. J.; Prockop, S. E.
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Allogeneic CD34-selected HSCT following CAR T-cells is associated with low TRM and favorable OS in pediatric/young adult patients with relapsed/refractory B-ALL
    Meeting Abstract

    Fabrizio, V.; Boulad, F.; Cancio, M. I.; Higman, M. A.; Margossian, S. P.; Mauguen, A.; Prockop, S.; Scaradavou, A.; Shah, N. C.; Spitzer, B.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • CAR T-cells followed by CD34-selected T-cell depleted (TCD) ALLO-HSCT is associated with low toxicity and favorable overall survival
    Meeting Abstract

    Fabrizio, V.; Boulad, F.; Cancio, M.; Margossian, S.; Mauguen, A.; Prockop, S.; Scaradavou, M.; Shah, N.; Spitzer, B.; Stieglitz, E.; more...
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save